BIOLARGO INC. BLGO
-
USD
(-)
- 15 min delayed data - NASDAQ OTCBB
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | BLGO |
| ISIN: |
BIOLARGO INC. BLGO news, videos and press releases
For more news please use our advanced search feature.
BIOLARGO INC. BLGO - More news...
BIOLARGO INC. BLGO - More news...
- 04/01/2025 - 09:30 Cleantech Innovator BioLargo Reports Record Revenues in 2024 Annual Report
- 03/28/2025 - 14:20 BioLargo Year-End 2024 Earnings Results Webcast and Conference Call on Monday, March 31, 2025 - 4:00 PM Eastern Time
- 03/10/2025 - 09:30 BioLargo Invited to Showcase PFAS Treatment Technology at Industry Leading Water Conference
- 01/15/2025 - 08:30 BioLargo Provides 2024 Review and 2025 Outlook
- 12/12/2024 - 08:30 BioLargo, Inc. CEO Dennis P. Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee (ETTAC)
- 12/03/2024 - 15:45 Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
- 11/15/2024 - 08:30 BioLargo's Year-to-Date Revenues Up 80%
- 11/13/2024 - 08:30 BioLargo Q3 2024 Earnings Results Webcast and Conference Call on Thursday, November 14, 2024 - 4:30 PM Eastern Time
- 11/12/2024 - 08:30 Sidoti Events, LLC's Virtual November Micro-Cap Conference
- 10/14/2024 - 08:30 BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology
- 09/16/2024 - 10:45 BioLargo to Host Ribbon-Cutting Event for Battery Pilot Manufacturing Facility
- 09/09/2024 - 08:30 Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical Officer
- 08/13/2024 - 08:30 BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time
- 08/06/2024 - 08:30 BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024
- 06/20/2024 - 08:30 BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract
- 06/12/2024 - 08:30 BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products
- 06/11/2024 - 08:30 BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
- 06/07/2024 - 11:55 BioLargo Engineering Secures Multi-Year Air Force Base Air Compliance Project
- 05/14/2024 - 17:10 BioLargo Generates Positive Operating Cash Flow on Record Quarterly Revenues for First Quarter of 2024
- 05/10/2024 - 08:30 BioLargo Q1 2024 Earnings Results Webcast and Conference Call on Tuesday, May 14, 2024 - 5:30 PM Eastern Time
- 04/23/2024 - 08:30 EPA Adds PFAS to CERCLA (Superfund) Law, Favoring Low-Waste Systems like BioLargo's AEC
- 04/15/2024 - 08:00 BioLargo PFAS Removal Technology Meets New US Drinking Water Standards
- 04/02/2024 - 08:00 BioLargo Achieved 108% Year-Over-Year Revenue Growth in 2023
- 04/01/2024 - 18:35 BioLargo Year-End 2023 Earnings Results Webcast and Conference Call on Tuesday, April 2, 2024 – 5:00 PM Eastern Time
- 02/20/2024 - 07:30 BioLargo Adds Larry Dick, Prominent Water Industry Veteran, to Board of Its Water Equipment Subsidiary
- 02/12/2024 - 07:30 BioLargo Recruits Sally Gutierrez, Former EPA Senior Advisor, for the Board of its Water Equipment and PFAS Solutions Company
- 02/05/2024 - 07:30 Jeffrey Kightlinger, Recognized Water Industry Leader, Joins Board of BioLargo's Water Equipment and PFAS Solutions Company
- 01/29/2024 - 07:30 BioLargo Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment
- 01/22/2024 - 07:30 BioLargo Doubles Annual Revenues - Again
- 12/20/2023 - 07:30 BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey
